See MaxCyte’s Rama Shivakumar at #SITC2025! She’ll present a poster on non-viral T cell engineering—showing how efficient CAR construct integration can be achieved using Flow Electroporation® technology. 📅 Nov 8 | Abstract #286 | Lower Atrium bit.ly/4ooU2Ya

Just over a week until #SITC2025! Meet the MaxCyte team in National Harbor. Stop by booth # 703 to learn how our Flow Electroporation® technology enables scalable, non-viral cell engineering. 🔗 bit.ly/49hbnOd

Heading to #PEGSEurope 2025? Visit Booth # 415 to connect with the MaxCyte team and see how our Flow Electroporation® technology enables seamless scale-up and reproducible cell engineering results. bit.ly/2O1uoKP #MaxCyte #CellEngineering #ProteinProduction

One week to #SITC2025! Stop by booth # 703 to connect with the MaxCyteteam. Learn how our Flow Electroporation® technology supports efficient, non-viral engineering for immunotherapy. bit.ly/49hbnOd

Join us Nov 12 in Cambridge for Strands of Innovation! Hear Nitin Kulkarni (MaxCyte) on enabling gene editing & cell therapy, plus talks from Baley Reeves (Texas A&M) and Daniel Dixon (TriLink Biotechnologies). 🎟️ Seats limited – register now! bit.ly/3LfpREn

Next week at #SITC2025: MaxCyte’s Rama Shivakumar will present a poster on advancing non-viral T cell engineering through efficient CAR construct integration using Flow Electroporation® technology. 📅 Nov 8 | Abstract #286 | Lower Atrium bit.ly/4ooU2Ya

Big congratulations to Caribou Biosciences on the exciting Phase 1 data from their allogeneic CAR-T programs in lymphoma and multiple myeloma! This milestone highlights meaningful progress for the entire field towards truly accessible, “off-the-shelf” CAR-T therapies.

Just days until #PEGSEurope 2025! Stop by Booth # 415 to chat with the MaxCyte team and learn how our Flow Electroporation® technology supports reproducible results from research to scale-up. bit.ly/2O1uoKP #CellEngineering #MaxCyte

MaxCyte’s Flow Electroporation® tech will be featured at the 20th Annual Meeting of KSGCT, Nov 6–7 at Catholic Univ. of Korea Visit Chayon Laboratories to explore how the MaxCyte® ExPERT™ platform powers innovation in gene & cell therapy. 🔗 bit.ly/43Heonq #KSGCT2025

#SITC2025 begins soon! Visit booth # 703 to meet the MaxCyte team and learn how our Flow Electroporation® technology powers scalable, non-viral cell engineering for immunotherapy.

1 week to Strands of Innovation! Hear Nitin Kulkarni (MaxCyte) on cell engineering for advanced therapies + Baley Reeves (Texas A&M) & Daniel Dixon (TriLink Biotechnologies) on mRNA and RNA innovation. 🕐 1–5 pm + happy hour 🎟️ Register now! bit.ly/3LfpREn

Excited for day one of SITC! Drop by and say hello to Eliza Fasbender, Sarah Schuett, Rama Shivakumar, and Nitin Kulkarni at booth #703. We're looking forward to catching up and connecting on your cell engineering needs over the next few days. bit.ly/49hbnOd

Happening tomorrow at #SITC2025! MaxCyte’s Rama Shivakumar will present a poster on advancing non-viral T cell engineering through efficient CAR construct integration using Flow Electroporation® technology. 📅 Nov 8 | Abstract #286 | Lower Atrium bit.ly/4ooU2Ya

Just days to go until Strands of Innovation in Cambridge! Hear Nitin Kulkarni (MaxCyte) + Baley Reeves (Texas A&M) & Daniel Dixon (TriLink Biotechnologies) share insights on cell & RNA innovation. bit.ly/3LfpREn

We’re live at #PEGSEurope 2025! Starting tomorrow, come by Booth #415 to meet the MaxCyte team and see how our Flow Electroporation® technology powers precise, scalable cell engineering. bit.ly/2O1uoKP #MaxCyte #CellEngineering

Day 1 of #PEGSEurope2025! We're having some great conversations about Flow Electroporation® technology and its applications. Don't forget to stop by booth #415 and say hello! We look forward to seeing you!

We’re heading to #AdvancedTherapiesUSA next week! 📅 Nov 18–19 | 📍 Philadelphia | Booth #603 bit.ly/4p4xCMb Stop by to meet the MaxCyte team and learn how our flow electroporation technology is powering innovation in #CellTherapy and #GeneTherapy.

Day 2 of #PEGSEurope! Linda's standout conversation topic of the day? "How HLA-agnostic TCRs can be used to target cancer cells." Want to go deeper? Check out this app note on how MaxCyte's tech enables TCR-based therapeutics discovery: bit.ly/4nOtbFo

We’re heading to Gothenburg for #ATMPSweden 2025! MaxCyte empowers the next generation of #AdvancedTherapies through better #CellEngineering. Stop by our booth (#10) to connect with the team driving cell & gene therapy forward. bit.ly/49tposd

That's a wrap on #PEGSEurope! Grateful for the conversations, the energy, and this fantastic team that made it all happen.